Market By Drugs & Devices And Geography | Forecast 2019-2027
Triton Market Research has estimated the Europe ophthalmology drugs and devices market to show upward growth and expand with a CAGR of 5.99% in the forecasting years 2019-2027.
The countries that have been analyzed in Europe’s ophthalmology drugs and devices market are:
• The United Kingdom
• France
• Germany
• Spain
• Italy
• Russia
• Rest of Europe
Report scope can be customized per your requirements. Request For Customization
The United Kingdom ophthalmology drugs and devices market is mainly driven by the escalating prevalence of ophthalmological disorders. According to the Royal National Institute of Blind People, age-related macular degeneration is the leading cause of blindness in the adult population, which is further followed by glaucoma, diabetic retinopathy and cataracts sight loss disorders. According to the institute, every day, around 250 people are beginning to lose their sight in the United Kingdom. As of the year 2015, more than 2 million individuals in the United Kingdom were reported to be living with eyesight disorders. According to the Royal Institute of Blind People, the number of individuals impacted by sight loss is expected to increase to around 2.7 million by the end of 2030; whereas, by the end of 2050, it is anticipated to reach around 4 million, which is further augmenting the growth of the ophthalmology drugs and devices market in the country.
The France ophthalmology drugs and devices market is mainly driven owing to the escalating prevalence of ophthalmological disorders, which mainly includes retinal vein occlusions and diabetic retinopathy. According to the European Society of Retina Specialists, approximately 85,000 individuals were affected by diabetic eye disease in 2017, which is anticipated to reach around 3 million by the end of 2050. The rising screening of diabetic retinopathy in France is estimated to be around 68%, which is precisely performed by fundoscopy in private ophthalmology practices in the country; this is paving the growth of the ophthalmology drugs and devices market in the country. According to the European Society of Retina Specialists, above 1 million individuals were estimated to be affected by retinal vein occlusions in 2017, which is anticipated to reach around 1.5 million by the end of 2050, further augmenting the growth of the ophthalmology drugs and devices market in the country.
Bayer AG is a Germany-based life sciences company, operating in verticals such as consumer health, pharmaceuticals, animal health and crop science. The company’s pharmaceuticals segment is engaged in the development of prescription pharmaceuticals; contraceptives, and medical products, such as injection systems and contrast agents for diagnostic procedures. In 2015, the company generated revenue worth $4103 million.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1.
EUROPE OPHTHALMOLOGY DRUGS AND DEVICES MARKET - SUMMARY
2.
INDUSTRY OUTLOOK
2.1. PORTER’S FIVE FORCE ANALYSIS
2.1.1.
BARGAINING POWER OF BUYERS
2.1.2.
BARGAINING POWER OF SUPPLIER
2.1.3.
THREATS OF NEW ENTRANTS
2.1.4.
THREATS OF SUBSTITUTES
2.1.5.
COMPETITIVE RIVALRY
2.2. STRATEGIC OUTLOOK
2.3. KEY INSIGHT
2.4. VALUE CHAIN OUTLOOK
2.5. KEY BUYING STANDARDS
2.6. SUPPLY CHAIN OUTLOOK
2.7. REGULATORY FRAMEWORK
2.8. MARKET DRIVERS
2.8.1.
INCREASING OPHTHALMIC DISORDERS DUE TO HIGH BLOOD SUGAR
2.8.2.
UPSURGE IN HEALTHCARE SPENDING
2.8.3.
TECHNOLOGICAL ADVANCEMENT
2.9. MARKET RESTRAINTS
2.9.1.
EXPIRATIONS OF BRAND PATENTS HAVE AFFECTED THE PHARMACEUTICAL INDUSTRY
2.9.2.
LOW COGNIZANCE RELATED TO OPHTHALMIC DRUGS
2.9.3.
DRUG APPROVALS DELAY AND NUMBER OF DRUGS IN THE PIPELINE
2.10.
MARKET OPPORTUNITIES
2.10.1.
DEMAND FOR PHACOEMULSIFICATION DEVICES AND INTRAOCULAR LENSES IS
INCREASING
2.11.
MARKET CHALLENGES
2.11.1.
DIFFICULTIES ASSOCIATED WITH THE CONDUCT OF OCULAR DISEASES
3.
OPHTHALMOLOGY DRUGS AND DEVICES MARKET OUTLOOK - BY DRUGS AND DEVICES
3.1. DEVICES
3.1.1.
DIAGNOSTIC & MONITORING EQUIPMENT
3.1.1.1.
OPTICAL COHERENCE TOMOGRAPHY
3.1.1.2.
OPHTHALMIC ULTRASOUND IMAGING SYSTEMS
3.1.1.3.
FUNDUS CAMERA MARKET
3.1.1.4.
OPHTHALMOSCOPES
3.1.1.5.
RETINOSCOPE
3.1.1.6.
PACHYMETER
3.1.1.7.
WAVEFRONT ABERROMETERS
3.1.1.8.
PERIMETERS/VISUAL FIELD ANALYZER
3.1.1.9.
AUTOREFRACTORS/PHOROPTER
3.1.1.10.
SPECULAR MICROSCOPE
3.1.1.11.
CORNEAL TOPOGRAPHERS
3.1.1.12.
OTHER DIAGNOSTIC & MONITORING EQUIPMENT MARKET
3.1.2.
SURGERY DEVICES
3.1.2.1.
CATARACT SURGERY DEVICES
3.1.2.2.
GLAUCOMA SURGERY DEVICES
3.1.2.3.
REFRACTIVE SURGERY DEVICES
3.1.2.4.
VITREORETINAL SURGERY DEVICES
3.1.3.
VISION CARE
3.2. DRUGS
3.2.1.
GLAUCOMA DRUG
3.2.2.
RETINAL DISORDER DRUG
3.2.3.
DRY EYE DRUG
3.2.4.
ALLERGIC CONJUNCTIVITIS, INFLAMMATION AND CONJUNCTIVITIS DRUG
3.2.5.
DRUGS BY USE OF PRESERVATION
3.2.5.1.
PRESERVED DRUGS
3.2.5.2.
PRESERVATIVE-FREE DRUGS
4.
OPHTHALMOLOGY DRUGS AND DEVICES MARKET - REGIONAL OUTLOOK
4.1. THE UNITED KINGDOM
4.2. FRANCE
4.3. GERMANY
4.4. SPAIN
4.5. ITALY
4.6. RUSSIA
4.7. REST OF EUROPE
5.
COMPETITIVE LANDSCAPE
5.1. ALLERGAN, INC.
5.2. BAYER
5.3. CARL ZEISS AG
5.4. ESSILOR INTERNATIONAL S.A.
5.5. GLAXOSMITHKLINE
5.6. JOHNSON & JOHNSON, INC.
5.7. NOVARTIS INTERNATIONAL AG
5.8. PFIZER
5.9. ROCHE HOLDING AG
5.10.
SANTEN PHARMACEUTICAL CO., LTD.
5.11.
SUN PHARMACEUTICALS INDUSTRIES, LTD.
5.12.
VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
5.13.
ZIEMER GROUP HOLDING AG
6.
METHODOLOGY AND SCOPE
6.1. RESEARCH SCOPE
6.2. SOURCES OF DATA
6.3. RESEARCH METHODOLOGY
TABLE 1 EUROPE OPHTHALMOLOGY
DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
TABLE 2 COMMON CAUSES OF
LOSS OF VISION IN THE ELDERLY
TABLE 3 SELECTED LIST OF
GLAUCOMA DRUGS IN LATE-STAGE CLINICAL TRIALS
TABLE 4 EUROPE OPHTHALMOLOGY
DRUGS AND DEVICES MARKET BY DRUGS AND DEVICES 2019-2027 ($ MILLION)
TABLE 5 EUROPE DEVICES
MARKET IN DIAGNOSTIC & MONITORING EQUIPMENT BY TYPES 2019-2027 ($ MILLION)
TABLE 6 EUROPE DEVICES
MARKET IN SURGERY DEVICE BY TYPES 2019-2027 ($ MILLION)
TABLE 7 EUROPE DRUGS AND
DEVICES MARKET IN DRUGS BY TYPES 2019-2027 ($ MILLION)
TABLE 8 EUROPE OPHTHALMOLOGY
DRUGS AND DEVICES MARKET BY COUNTRIES 2019-2027 ($ MILLION)
FIGURE 1 EUROPE OPHTHALMOLOGY
DRUGS AND DEVICES MARKET 2019-2027
FIGURE 2 EUROPE DRUGS AND
DEVICES MARKET IN DEVICES 2019-2027 ($ MILLION)
FIGURE 3 EUROPE DEVICES MARKET
DIAGNOSTIC & MONITORING EQUIPMENT IN 2019-2027 ($ MILLION)
FIGURE 4 EUROPE DIAGNOSTIC
& MONITORING EQUIPMENT MARKET IN OPTICAL COHERENCE TOMOGRAPHY 2019-2027 ($
MILLION)
FIGURE 5 EUROPE DIAGNOSTIC
& MONITORING EQUIPMENT MARKET IN OPHTHALMIC ULTRASOUND IMAGING SYSTEMS
2019-2027 ($ MILLION)
FIGURE 6 EUROPE DIAGNOSTIC
& MONITORING EQUIPMENT MARKET IN FUNDUS CAMERA MARKET 2019-2027 ($ MILLION)
FIGURE 7 EUROPE DIAGNOSTIC
& MONITORING EQUIPMENT MARKET IN OPHTHALMOSCOPES 2019-2027 ($ MILLION)
FIGURE 8 EUROPE DIAGNOSTIC
& MONITORING EQUIPMENT MARKET IN RETINOSCOPE 2019-2027 ($ MILLION)
FIGURE 9 EUROPE DIAGNOSTIC
& MONITORING EQUIPMENT MARKET IN PACHYMETER 2019-2027 ($ MILLION)
FIGURE 10 EUROPE DIAGNOSTIC &
MONITORING EQUIPMENT MARKET IN WAVEFRONT ABERROMETERS 2019-2027 ($ MILLION)
FIGURE 11 EUROPE DIAGNOSTIC
& MONITORING EQUIPMENT MARKET IN PERIMETERS/VISUAL FIELD ANALYZER 2019-2027
($ MILLION)
FIGURE 12 EUROPE DIAGNOSTIC &
MONITORING EQUIPMENT MARKET IN AUTOREFRACTORS/PHOROPTER 2019-2027 ($ MILLION)
FIGURE 13 EUROPE DIAGNOSTIC &
MONITORING EQUIPMENT MARKET IN SPECULAR MICROSCOPE 2019-2027 ($ MILLION)
FIGURE 14 EUROPE DIAGNOSTIC &
MONITORING EQUIPMENT MARKET IN CORNEAL TOPOGRAPHERS 2019-2027 ($ MILLION)
FIGURE 15 EUROPE DIAGNOSTIC &
MONITORING EQUIPMENT MARKET IN OTHER DIAGNOSTIC & MONITORING EQUIPMENT
MARKET 2019-2027 ($ MILLION)
FIGURE 16 EUROPE DEVICES MARKET
IN SURGERY DEVICE 2019-2027 ($ MILLION)
FIGURE 17 EUROPE SURGERY DEVICES
MARKET IN CATARACT SURGERY DEVICES 2019-2027 ($ MILLION)
FIGURE 18 EUROPE SURGERY DEVICES
MARKET IN GLAUCOMA SURGERY DEVICES 2019-2027 ($ MILLION)
FIGURE 19 EUROPE SURGERY DEVICES
MARKET IN REFRACTIVE SURGERY DEVICES 2019-2027 ($ MILLION)
FIGURE 20 EUROPE SURGERY DEVICES
MARKET IN VITREORETINAL SURGERY DEVICES 2019-2027 ($ MILLION)
FIGURE 21 EUROPE DEVICES MARKET
IN VISION CARE MARKET 2019-2027 ($ MILLION)
FIGURE 22 EUROPE DRUGS AND
DEVICES MARKET IN DRUGS 2019-2027 ($ MILLION)
FIGURE 23 EUROPE DRUGS MARKET IN
GLAUCOMA DRUG 2019-2027 ($ MILLION)
FIGURE 24 EUROPE DRUGS MARKET IN
RETINAL DISORDER DRUG 2019-2027 ($ MILLION)
FIGURE 25 EUROPE DRUGS MARKET IN
DRY EYE DRUG 2019-2027 ($ MILLION)
FIGURE 26 EUROPE DRUGS MARKET IN
ALLERGIC CONJUNCTIVITIS, INFLAMMATION AND CONJUNCTIVITIS DRUG 2019-2027 ($
MILLION)
FIGURE 27 EUROPE DRUGS BY USE OF
PRESERVATION IN PRESERVED DRUGS 2019-2027 ($ MILLION)
FIGURE 28 EUROPE DRUGS BY USE OF
PRESERVATION IN PRESERVATIVE-FREE DRUGS 2019-2027 ($ MILLION)
FIGURE 29 EUROPE
PRESERVATIVE-FREE DRUGS MARKET IN SINGLE-DOSE 2019-2027 ($ MILLION)
FIGURE 30 EUROPE
PRESERVATIVE-FREE DRUGS MARKET IN MULTI-DOSE 2019-2027 ($ MILLION)
FIGURE 31 THE UNITED KINGDOM
OPHTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 32 FRANCE OPHTHALMOLOGY
DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 33 GERMANY OPHTHALMOLOGY
DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 34 SPAIN OPHTHALMOLOGY
DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 35 ITALY OPHTHALMOLOGY
DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 36 RUSSIA OPHTHALMOLOGY
DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)
FIGURE 37 REST
OF EUROPE OPHTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)